API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

4-Acetoxystyrene: A Versatile Monomer with Applications in Polymerization and Immunosensing

4-Acetoxystyrene is a versatile monomer used in polymerization and immunosensing applications, but it requires careful handling due to its toxicity and environmental risks.

Jan 31,2024  API

Scientific opinion on the safety assessment of (Perfluorobutyl)ethylene for use in food contact materials

The CEF Panel concluded that there is no safety concern for the consumer if the substance is used as co-monomer up to 0.1% w/w in the polymerisation of fluoropolymers that are processed at high temp

Jan 30,2024  API

Grape Seed Extract Shows Promise as a Potential Treatment for Neurodegenerative Disorders

Grape Seed Extract shows potential in treating neurodegenerative diseases by reducing oxidative stress, inflammation, and improving cognitive function.

Jan 30,2024  API

Mometasone furoate for the treatment of asthma

Mometasone furoate is a potent glucocorticoid that reduces inflammation and has high efficacy in treating asthma, especially when used intranasally or inhaled.

Jan 30,2024  API

Capecitabine for the treatment of pancreatic cancer

Capecitabine is an oral chemotherapy drug used for colorectal and breast cancer. It has shown promise in treating locally advanced pancreatic cancer when combined with radiation therapy.

Jan 30,2024  API

Acesulfame: Properties as Food Additive, Scope of Use and Safety

Acesulfame is a stable, sweet, and inexpensive white powder used as a synthetic sweetener in various food and beverage products worldwide.

Jan 30,2024  API

Palmitoyl Pentapeptide: Biological Roles, Mechanisms of Anti-ageing, Efficacy and Applications

Palmitoyl Pentapeptide promotes collagen synthesis, reduces wrinkles, improves skin texture, and is widely used in skincare products for wound healing and anti-aging benefits.

Jan 30,2024  API

The Mechanism of Calcitriol in Cancer Treatment

Calcitriol regulates cell cycle, induces apoptosis, and promotes cell differentiation, contributing to its anti-cancer effects.

Jan 30,2024  API

Mycophenolate mofetil: pharmacokinetics, mechanism of action and applications in dermatology

Mycophenolate mofetilis can be converted to mycophenolic acid and inhibit T and B cell proliferation via depletion of guanosine nucleotides, showing promise in treating inflammatory skin diseases.

Jan 29,2024  API

OMadacycline (Tosylate): A Promising Tetracycline Antibiotic for the Treatment of Bacterial Infections

OMadacycline (tosylate) is a potent tetracycline antibiotic that inhibits bacterial protein synthesis by binding to ribosome, with broad effectiveness against resistant strains and moderate half-life.

Jan 29,2024  API
Prev12345678910...Next>  Go to Page